# INOPASE - Performance and Safety Study of a Personalised SNM System

> **NCT07193407** · NA · RECRUITING · sponsor: **INOPASE Pty Ltd** · enrollment: 10 (estimated)

## Conditions studied

- Overactive Bladder (OAB)

## Interventions

- **DEVICE:** Sacral Neuromodulation System

## Key facts

- **NCT ID:** NCT07193407
- **Lead sponsor:** INOPASE Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-27
- **Primary completion:** 2026-10-02
- **Final completion:** 2026-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07193407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07193407, "INOPASE - Performance and Safety Study of a Personalised SNM System". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07193407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*